Sinopharm To Restructure Xinjiang Pharmaceutical
This article was originally published in PharmAsia News
Executive Summary
Sinopharm has agreed to acquire Xinjiang Pharmaceutical Group, part of State-owned Assets Supervision and Administration Commission of Xinjiang Autonomous Region. Sinopharm plans to strengthen Xinjiang Pharmaceutical into a more competitive drug corporation in Northwest China by pumping in funds as well as providing support such as technology, management and training. With its edge in specialized ethnic medicine, Xinjiang Pharmaceutical accounts for half of the region's pharmaceutical distribution business. Sinopharm has been seeking pharmaceutical firms with good value in its bid to further reinforce its top position in the industry. (Click here for more - Chinese Language)